Comparison of Pediatric and Adult Glucagon-Like Peptide-1 Receptor Agonist Exposures Reported To United States Poison Centers, 2017–2024

View Full Paper

Ask AI

Bookmark

Share

Key Points

To compare glucagon-like peptide-1 receptor agonist exposures in pediatric versus adult populations as reported to U.S. poison centers.
Analyzed national poison center data from 2017 to 2024.
Compared incidence of exposures and toxicity levels between age groups.
Evaluated clinical implications of findings for healthcare professionals.
Identified varying exposure rates to GLP-1 receptor agonists between children and adults.
Reported significantly differing toxicity patterns based on age.
Found national exposure trends that may affect clinical recommendations.

We only have this paper's title and publication details.

Comparison reveals differences in GLP-1 receptor agonist exposure between adults and children, suggesting a need for tailored clinical practices.

This study provides national-level, real-world findings that may help inform clinical practice.

No takes yet. Share an insight, caveat, or question.

Senthilkumar et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark

Share